OL
CL icon

Optas LLC’s Colgate-Palmolive CL Stock Holding History

Optas LLC’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.58M Buy
17,195
+355
+2% +$31.1K 0.22% 58
2026
Q1 		$1.44M Sell
16,840
-275
-2% -$24.5K 0.22% 58
2025
Q4 		$1.35M Sell
17,115
-11,693
-41% -$917K 0.21% 56
2025
Q3 		$2.3M Buy
28,808
+13,269
+85% +$1.13M 0.39% 40
2025
Q2 		$1.41M Sell
15,539
-358
-2% -$32.7K 0.27% 52
2025
Q1 		$1.49M Buy
15,897
+1,439
+10% +$129K 0.26% 47
2024
Q4 		$1.31M Buy
14,458
+431
+3% +$41.1K 0.28% 49
2024
Q3 		$1.46M Buy
14,027
+8,623
+160% +$879K 0.33% 44
2024
Q2 		$524K Sell
5,404
-39
-0.7% -$3.6K 0.14% 82
2024
Q1 		$490K Sell
5,443
-129
-2% -$10.9K 0.13% 92
2023
Q4 		$444K Buy
5,572
+260
+5% +$19.5K 0.13% 94
2023
Q3 		$378K Sell
5,312
-4,807
-48% -$359K 0.13% 101
2023
Q2 		$780K Sell
10,119
-6
-0.1% -$464 0.26% 65
2023
Q1 		$761K Sell
10,125
-464
-4% -$34.5K 0.27% 63
2022
Q4 		$834K Sell
10,589
-174
-2% -$13K 0.34% 50
2022
Q3 		$753K Buy
10,763
+122
+1% +$9.57K 0.33% 49
2022
Q2 		$852K Buy
10,641
+894
+9% +$69.9K 0.35% 44
2022
Q1 		$740K Buy
9,747
+60
+0.6% +$4.75K 0.24% 64
2021
Q4 		$826K Buy
9,687
+105
+1% +$8.2K 0.23% 66
2021
Q3 		$725K Sell
9,582
-21
-0.2% -$1.67K 0.21% 64
2021
Q2 		$781K Sell
9,603
-49
-0.5% -$4.01K 0.22% 60
2021
Q1 		$761K Buy
9,652
+4,206
+77% +$330K 0.24% 57
2020
Q4 		$466K Sell
5,446
-5,185
-49% -$429K 0.15% 85
2020
Q3 		$819K Buy
10,631
+5,343
+101% +$407K 0.25% 70
2020
Q2 		$387K Sell
5,288
-2,109
-29% -$150K 0.16% 78
2020
Q1 		$490K Buy
7,397
+3,493
+89% +$246K 0.24% 59
2019
Q4 		$269K Buy
+3,904
New +$266K 0.1% 127

Other funds holding CL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Optas LLC's CL Position: Q2 2026 in Review

Optas LLC increased its Colgate-Palmolive (CL) stake by 2.1% in Q2 2026, buying an estimated $31.1K and bringing the position to 17,195 shares worth $1.58M. The position accounts for 0.22% of the portfolio, ranked #58.

Optas LLC first reported a position in CL in Q4 2019 and has held it in 27 quarters since. The position peaked at $2.3M in Q3 2025. 2,011 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Optas LLC held 17,195 shares of Colgate-Palmolive worth $1.58M as of Q2 2026.
  • Optas LLC bought 355 Colgate-Palmolive shares in Q2 2026, an estimated $31.1K.
  • Colgate-Palmolive made up 0.22% of Optas LLC's portfolio in Q2 2026, its #58 holding.
  • Optas LLC first reported a position in Colgate-Palmolive in Q4 2019 and has held it in 27 quarters since.
  • Optas LLC's Colgate-Palmolive position peaked at $2.3M in Q3 2025.
  • 2,011 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Optas LLC's 13F filing for Q2 2026, filed 21 Jul 2026.